Developing a data commons for cancer immune monitoring and analysis.
Official title: CLINICAL AND TRANSLATIONAL DATA COMMONS (CTDC) AND IMMUNE ONCOLOGY DATA HARMONIZATION/MAPPING (IODH/M)
Funded at Leidos Biomedical Research, INC. · NIH-11219255 · Data updated 2026-11-12
This study is working to bring together and organize important cancer-related information, especially about how the immune system responds to cancer, so that researchers can easily access high-quality data to help develop better treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | September 25, 2024 |
| Project end | September 24, 2027 |
| Funding year | 2024 |
| Award (this year) | $7,499,979 |
| NIH project number | 75N91019D00024-0-759102400035-1 |
| Project ID | NIH-11219255 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include patients involved in clinical trials for cancer immunotherapies.
✕Less likely to help
Patients with cancers that are not part of the immuno-oncology focus may not receive direct benefits from this research.
What this research studies
This project focuses on creating and maintaining a comprehensive data commons that integrates various cancer-related datasets, particularly those related to immune monitoring. It aims to standardize and harmonize data from multiple sources, including clinical trials and biological assays, to ensure high-quality data is available for researchers and the public. By automating workflows for data validation and curation, the project seeks to enhance the accessibility and usability of cancer immunology data. Patients may benefit from improved research outcomes and more effective treatments based on this harmonized data.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by providing researchers with high-quality, standardized data.
How similar studies have gone: Other research initiatives have successfully utilized data commons approaches to enhance cancer research, indicating a promising potential for this project.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
Related research
Other NIH-funded projects on the same topics.
-
Improving public health responses to COVID-19 through standardized testing.
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
-
Creating a large library of cancer models for research use
This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.
-
Advancing global cancer control through data analysis and international collaboration
This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.
-
Support for HIV and HPV cancer prevention clinical trials in the Americas
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
-
Development and production of clinical-grade biopharmaceuticals
This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.
-
Understanding the immune response to COVID-19
This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.